Literature DB >> 12020858

Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats.

Anthony E Kline1, Bryan D Bolinger, Patrick M Kochanek, Timothy M Carlos, Hong Q Yan, Larry W Jenkins, Donald W Marion, C Edward Dixon.   

Abstract

Traumatic injury to the central nervous system initiates inflammatory processes such as the synthesis of proinflammatory mediators that contribute to secondary tissue damage. Hence, administration of anti-inflammatory cytokines, such as interleukin-10 (IL-10) may be neuroprotective. Moderate hypothermia (30-32 degrees C) also decreases the pro-inflammatory response to traumatic brain injury (TBI). Thus, we hypothesized that the combination of IL-10 and hypothermia would provide synergistic neuroprotective effects after TBI. To test this hypothesis, fifty isoflurane-anesthetized rats underwent a controlled cortical impact (2.7 mm tissue deformation at 4 m/s) or sham injury and then were randomly assigned to one of five conditions (TBI/VEH Normothermia (37 degrees C), TBI/VEH Hypothermia (32 degrees C for 3 h), TBI/IL-10 Normothermia, TBI/IL-10 Hypothermia, and Sham/VEH Normothermia). Human IL-10 (5 microg) or VEH was administered (i.p.) 30 min after surgery. Function was assessed by established motor and cognitive tests on post-operative days 1-5 and 14-18, respectively. Cortical lesion volume and hippocampal CA(1)/CA(3) cell survival were quantified at 4 weeks. Brain sections from 15 additional rats were immunohistochemically assessed (MoAB RP-3) to determine neutrophil accumulation at 5 h after TBI. The administration of IL-10 after TBI produced an approximately 75% reduction in the number of RP-3-positive cells in both the normothermic and hypothermic groups vs. the normothermic vehicle-treated group (P<0.05), but did not improve functional outcome. In contrast, hypothermia alone enhanced both motor and cognitive function and increased CA(3) neuronal survival after TBI. Contrary to our hypothesis, systemic administration of IL-10 combined with hypothermia did not provide synergistic neuroprotective effects after TBI. Rather, IL-10 administration suppressed the beneficial effects produced by hypothermia alone after TBI. The mechanism(s) for the negative effects of IL-10 combined with hypothermia after TBI remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020858     DOI: 10.1016/s0006-8993(02)02458-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.

Authors:  Anthony E Kline; Adam S Olsen; Christopher N Sozda; Ann N Hoffman; Jeffrey P Cheng
Journal:  J Neurotrauma       Date:  2012-05-21       Impact factor: 5.269

Review 2.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

4.  YKL-40 expression in traumatic brain injury: an initial analysis.

Authors:  Dafna Bonneh-Barkay; Pavel Zagadailov; Huichao Zou; Christian Niyonkuru; Matthew Figley; Adam Starkey; Guoji Wang; Stephanie J Bissel; Clayton A Wiley; Amy K Wagner
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

Review 5.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

6.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

7.  Abbreviated environmental enrichment confers neurobehavioral, cognitive, and histological benefits in brain-injured female rats.

Authors:  Hannah L Radabaugh; Lauren J Carlson; Darik A O'Neil; Megan J LaPorte; Christina M Monaco; Jeffrey P Cheng; Patricia B de la Tremblaye; Naima Lajud; Corina O Bondi; Anthony E Kline
Journal:  Exp Neurol       Date:  2016-09-28       Impact factor: 5.330

8.  The Therapeutic Efficacy of Environmental Enrichment and Methylphenidate Alone and in Combination after Controlled Cortical Impact Injury.

Authors:  Jacob B Leary; Corina O Bondi; Megan J LaPorte; Lauren J Carlson; Hannah L Radabaugh; Jeffrey P Cheng; Anthony E Kline
Journal:  J Neurotrauma       Date:  2016-05-09       Impact factor: 5.269

9.  Regulation of therapeutic hypothermia on inflammatory cytokines, microglia polarization, migration and functional recovery after ischemic stroke in mice.

Authors:  Jin Hwan Lee; Zheng Z Wei; Wenyuan Cao; Soonmi Won; Xiaohuan Gu; Megan Winter; Thomas A Dix; Ling Wei; Shan Ping Yu
Journal:  Neurobiol Dis       Date:  2016-09-19       Impact factor: 5.996

10.  A combined therapeutic regimen of buspirone and environmental enrichment is more efficacious than either alone in enhancing spatial learning in brain-injured pediatric rats.

Authors:  Christina M Monaco; Kory M Gebhardt; Sarah M Chlebowski; Kaitlyn E Shaw; Jeffrey P Cheng; Jeremy J Henchir; Margaret F Zupa; Anthony E Kline
Journal:  J Neurotrauma       Date:  2014-09-29       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.